Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.87% | 285.76 | 1.5% | $877.84m | |
| GILD | Gilead Sciences, Inc. | -0.19% | 87.79 | 1.0% | $684.30m | |
| MRNA | Moderna, Inc. | 3.15% | 179.00 | 0.0% | $651.73m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.25% | 764.27 | 2.6% | $499.64m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.85% | 317.58 | 1.9% | $473.10m | |
| BIIB | Biogen, Inc. | 0.23% | 292.15 | 1.8% | $407.81m | |
| ILMN | Illumina, Inc. | 1.23% | 208.52 | 3.2% | $225.94m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.44% | 103.69 | 4.2% | $162.19m | |
| BNTX | BioNTech SE | 0.63% | 162.63 | 0.0% | $150.70m | |
| AXSM | Axsome Therapeutics, Inc. | 3.85% | 78.16 | 1.6% | $146.95m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -3.98% | 1.93 | 0.7% | $134.91m | |
| RXDX | Prometheus Biosciences, Inc | 165.67% | 95.80 | 1.4% | $103.84m | |
| MRTX | Mirati Therapeutics, Inc. | -30.66% | 49.59 | 1.6% | $102.08m | |
| HALO | Halozyme Therapeutics, Inc. | 2.41% | 57.74 | 18.4% | $82.03m | |
| NVAX | Novavax, Inc. | 2.62% | 17.22 | 75.3% | $81.88m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.